Portfolio of Bridgewater Associates
Bridgewater Associates was founded by Ray Dalio, who handed over leadership in 2022; the hedge fund follows a macroeconomic approach with a broadly diversified portfolio.
Source: 13F filing with the US Securities and Exchange Commission dated Nov 13, 2025. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q3 2025. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 25.5B USD
- Positions
- 1,014
- Share of the ten largest
- 32.5%
The ten largest positions Q3 2025
- Ishares TR 10.6%▲ +75.3%
- SPDR S&P 500 ETF TR 6.7%▼ −1.7%
- Alphabet Inc. (Class A) 2.5%▼ −52.6%
- Microsoft 2.2%▼ −36.0%
- Salesforce 1.9%▲ +22.4%
- Nvidia 1.8%▼ −65.3%
- Lam Research 1.8%▲ +111.4%
- Adobe Inc. 1.7%▲ +73.1%
- Booking Holdings 1.6%▲ +2.1%
- GE Vernova 1.6%▼ −16.3%
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q3 2025
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| SPDR S&P 500 ETF TR | 6.7% | 2,565,088 | 1.7B USD | −1.7% reduced | Q2 2013 or earlier 50 quarters |
| Ishares TR | 0.4% | 962,500 | 107.3M USD | −7.0% reduced | Q2 2013 or earlier 50 quarters |
| Ishares Inc | 0.3% | 1,161,001 | 76.5M USD | −93.2% reduced | Q3 2016 37 quarters |
| DHI D. R. Horton | < 0.1% | 1,627 | 275.7K USD | −99.5% reduced | Q4 2019 24 quarters |
| HCA HCA Healthcare | 0.6% | 340,557 | 145.1M USD | −16.3% reduced | Q1 2020 23 quarters |
| UHS Universal Health Services | 0.2% | 289,987 | 59.3M USD | −12.0% reduced | Q1 2020 23 quarters |
| MCK McKesson Corporation | 0.2% | 56,139 | 43.4M USD | −62.0% reduced | Q1 2020 23 quarters |
| KR Kroger | < 0.1% | 74,161 | 5.0M USD | −91.7% reduced | Q1 2020 23 quarters |
| Smucker J M Co | < 0.1% | 6,751 | 733.2K USD | −40.8% reduced | Q1 2020 23 quarters |
| HSIC Henry Schein | < 0.1% | 3,469 | 230.2K USD | −1.4% reduced | Q1 2020 23 quarters |
| JNJ Johnson & Johnson | 1.2% | 1,715,777 | 318.1M USD | −24.8% reduced | Q3 2020 21 quarters |
| COR Cencora | < 0.1% | 50,326 | 15.7M USD | −55.4% reduced | Q3 2020 21 quarters |
| EW Edwards Lifesciences | < 0.1% | 180,307 | 14.0M USD | −59.5% reduced | Q3 2020 21 quarters |
| Grand Canyon Ed Inc | < 0.1% | 43,829 | 9.6M USD | −12.6% reduced | Q3 2020 21 quarters |
| DXCM Dexcom | < 0.1% | 120,495 | 8.1M USD | −52.5% reduced | Q3 2020 21 quarters |
| Kellanova | < 0.1% | 20,830 | 1.7M USD | −7.7% reduced | Q3 2020 21 quarters |
| Molson Coors Beverage Co | < 0.1% | 29,717 | 1.3M USD | −65.1% reduced | Q3 2020 21 quarters |
| Penumbra Inc | < 0.1% | 1,280 | 324.3K USD | −61.4% reduced | Q3 2020 21 quarters |
| GOOGL Alphabet Inc. (Class A) | 2.5% | 2,653,896 | 645.2M USD | −52.6% reduced | Q4 2020 20 quarters |
| MSFT Microsoft | 2.2% | 1,097,169 | 568.3M USD | −36.0% reduced | Q4 2020 20 quarters |
| META Meta Platforms | 1.2% | 416,919 | 306.2M USD | −48.3% reduced | Q4 2020 20 quarters |
| CSCO Cisco | 0.5% | 1,786,488 | 122.2M USD | −4.7% reduced | Q4 2020 20 quarters |
| BNY BNY Mellon | 0.2% | 400,747 | 43.7M USD | −27.4% reduced | Q4 2020 20 quarters |
| GILD Gilead Sciences | 0.2% | 385,364 | 42.8M USD | −42.2% reduced | Q4 2020 20 quarters |
| Affiliated Managers Group In | < 0.1% | 14,334 | 3.4M USD | −87.0% reduced | Q4 2020 20 quarters |
| Bausch Health Cos Inc | < 0.1% | 436,553 | 2.8M USD | −41.4% reduced | Q4 2020 20 quarters |
| CMCSA Comcast | 0.8% | 6,859,625 | 215.5M USD | −21.2% reduced | Q1 2021 19 quarters |
| Toll Brothers Inc | 0.2% | 394,421 | 54.5M USD | −8.9% reduced | Q1 2021 19 quarters |
| TPR Tapestry, Inc. | 0.1% | 250,693 | 28.4M USD | −60.8% reduced | Q1 2021 19 quarters |
| PHM PulteGroup | 0.1% | 206,085 | 27.2M USD | −80.1% reduced | Q1 2021 19 quarters |
| Gentex Corp | 0.1% | 952,358 | 27.0M USD | −19.8% reduced | Q1 2021 19 quarters |
| BMY Bristol Myers Squibb | < 0.1% | 444,032 | 20.0M USD | −83.6% reduced | Q1 2021 19 quarters |
| Inspire Med Sys Inc | < 0.1% | 88,952 | 6.6M USD | −37.2% reduced | Q1 2021 19 quarters |
| CI Cigna | 0.7% | 603,139 | 173.9M USD | −2.2% reduced | Q2 2021 18 quarters |
| ABBV AbbVie | 0.2% | 260,689 | 60.4M USD | −56.4% reduced | Q2 2021 18 quarters |
| MRK Merck & Co. | 0.2% | 513,943 | 43.1M USD | −55.3% reduced | Q2 2021 18 quarters |
| AZN AstraZeneca | 0.1% | 462,859 | 35.5M USD | −25.5% reduced | Q2 2021 18 quarters |
| Unum Group | 0.1% | 436,084 | 33.9M USD | −22.4% reduced | Q2 2021 18 quarters |
| Lantheus HLDGS Inc | < 0.1% | 296,918 | 15.2M USD | −25.4% reduced | Q2 2021 18 quarters |
| Sprouts Fmrs Mkt Inc | < 0.1% | 134,955 | 14.7M USD | −29.4% reduced | Q2 2021 18 quarters |
| Adtalem Global Ed Inc | < 0.1% | 79,951 | 12.3M USD | −56.0% reduced | Q2 2021 18 quarters |
| INCY Incyte | < 0.1% | 131,284 | 11.1M USD | −66.7% reduced | Q2 2021 18 quarters |
| DVA DaVita | < 0.1% | 26,804 | 3.6M USD | −76.1% reduced | Q2 2021 18 quarters |
| Rio Tinto PLC | < 0.1% | 4,073 | 268.9K USD | −99.3% reduced | Q2 2021 18 quarters |
| MO Altria | 1.0% | 3,695,606 | 244.1M USD | −2.0% reduced | Q3 2021 17 quarters |
| GPN Global Payments | 0.4% | 1,247,587 | 103.6M USD | −6.7% reduced | Q3 2021 17 quarters |
| PM Philip Morris International | < 0.1% | 154,315 | 25.0M USD | −20.3% reduced | Q3 2021 17 quarters |
| ELV Elevance Health | < 0.1% | 55,203 | 17.8M USD | −6.2% reduced | Q3 2021 17 quarters |
| QCOM Qualcomm | 0.3% | 531,040 | 88.3M USD | −30.5% reduced | Q4 2021 16 quarters |
| GE GE Aerospace | 0.2% | 131,528 | 39.6M USD | −8.7% reduced | Q4 2021 16 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Show more (up to 500) Shown: the 50 longest-held of 190 positions.
Breakdown by sector
- Technology 21.3%
- Financials 10.2%
- Communication Services 5.9%
- Health Care 5.8%
- Industrials 5.1%
- Consumer Discretionary 4.7%
- Consumer Staples 2.0%
- Energy 1.0%
- Utilities 0.7%
- Materials 0.3%
- Real Estate 0.2%
- not in our coverage 42.8%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors